<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="research-article" dtd-version="2.3" xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Chem.</journal-id>
<journal-title>Frontiers in Chemistry</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Chem.</abbrev-journal-title>
<issn pub-type="epub">2296-2646</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">1219986</article-id>
<article-id pub-id-type="doi">10.3389/fchem.2023.1219986</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Chemistry</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Pyrazole&#x2010;promoted synthesis of pyrrolo[3,4&#x2010;c] quinoline-1,3&#x2010;diones in a novel diketene-based reaction</article-title>
<alt-title alt-title-type="left-running-head">Rezvanian and Esfandsar</alt-title>
<alt-title alt-title-type="right-running-head">
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fchem.2023.1219986">10.3389/fchem.2023.1219986</ext-link>
</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Rezvanian</surname>
<given-names>Atieh</given-names>
</name>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1979790/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Esfandsar</surname>
<given-names>Zahra</given-names>
</name>
</contrib>
</contrib-group>
<aff>
<institution>Department of Organic Chemistry</institution>, <institution>Faculty of Chemistry</institution>, <institution>Alzahra University</institution>, <addr-line>Tehran</addr-line>, <country>Iran</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>
<bold>Edited by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/407520/overview">Guigen Li</ext-link>, Texas Tech University, United States</p>
</fn>
<fn fn-type="edited-by">
<p>
<bold>Reviewed by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/855802/overview">Bubun Banerjee</ext-link>, Akal University, India</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/2076464/overview">S. Hassan Hosseini</ext-link>, University of Science and Technology of Mazandaran, Iran</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/2128818/overview">Yanrong Li</ext-link>, Boston College, United States</p>
</fn>
<corresp id="c001">&#x2a;Correspondence: Atieh Rezvanian, <email>rezvaniana@alzahra.ac.ir</email>
</corresp>
</author-notes>
<pub-date pub-type="epub">
<day>26</day>
<month>09</month>
<year>2023</year>
</pub-date>
<pub-date pub-type="collection">
<year>2023</year>
</pub-date>
<volume>11</volume>
<elocation-id>1219986</elocation-id>
<history>
<date date-type="received">
<day>09</day>
<month>05</month>
<year>2023</year>
</date>
<date date-type="accepted">
<day>08</day>
<month>09</month>
<year>2023</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2023 Rezvanian and Esfandsar.</copyright-statement>
<copyright-year>2023</copyright-year>
<copyright-holder>Rezvanian and Esfandsar</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<p>We describe the first classic example of green synthesis of pyrrolo[3,4-c]quinolones scaffolds by catalyst-free unusual reaction of diketene, isatin, and primary amines in ethanol in the presence of pyrazole as a promoter for 4&#xa0;h. The whole structure of the new product was confirmed by X-ray analysis. The overall transformation involves the cleavage and generation of multiple carbon-nitrogen and carbon-carbon bonds. This report represents a simple and straightforward approach for the synthesis of pyrrolo[3,4-c]quinoline-1,3-diones, which has significant advantages like readily available precursors, non-use of toxic solvent, operational simplicity, mild conditions, good atom economy, and excellent yields; therefore it provides a green and sustainable strategy for access to a range of interesting <italic>N</italic>-containing heterocyclic compounds in medicinal and organic chemistry.</p>
</abstract>
<abstract abstract-type="graphical">
<title>Graphical Abstract</title>
<p>
<graphic xlink:href="FCHEM_fchem-2023-1219986_wc_abs.tif" position="anchor"/>
</p>
</abstract>
<kwd-group>
<kwd>pyrrolo[3,4-c]quinolones</kwd>
<kwd>pyrazole</kwd>
<kwd>diketene</kwd>
<kwd>heterocycles</kwd>
<kwd>green solvent</kwd>
<kwd>multicomponent reaction</kwd>
</kwd-group>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Organic Chemistry</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec id="s1">
<title>1 Introduction</title>
<p>Quinolines have received lots of attention from biologists and chemists as they are significant elements in the synthesis of dyes, fragrances, and natural products with biological activities (<xref ref-type="bibr" rid="B44">Michael, 2001</xref>; <xref ref-type="bibr" rid="B45">Michael, 2002</xref>; <xref ref-type="bibr" rid="B46">Michael, 2003</xref>; <xref ref-type="bibr" rid="B47">Michael, 2004</xref>; <xref ref-type="bibr" rid="B48">Michael, 2005</xref>; <xref ref-type="bibr" rid="B49">Michael, 2007</xref>; <xref ref-type="bibr" rid="B50">Michael, 2008</xref>; <xref ref-type="bibr" rid="B23">Isaac-M&#xe1;rquez et al., 2010</xref>; <xref ref-type="bibr" rid="B5">Cai et al., 2011</xref>; <xref ref-type="bibr" rid="B72">Russ et al., 2012</xref>). In pharmaceuticals, they have been outlined as, antibiotic (<xref ref-type="bibr" rid="B40">Mahamoud et al., 2006</xref>), anticancer (<xref ref-type="bibr" rid="B22">Insuasty et al., 2013</xref>; <xref ref-type="bibr" rid="B85">Sun et al., 2013</xref>), anti-inflammatory (<xref ref-type="bibr" rid="B34">Leatham et al., 1983</xref>), antimalarial (<xref ref-type="bibr" rid="B54">Nasveld and Kitchener, 2005</xref>), antihypertensive (<xref ref-type="bibr" rid="B53">Muruganantham et al., 2004</xref>), anti-HIV (<xref ref-type="bibr" rid="B83">Strekowski et al., 1991</xref>; <xref ref-type="bibr" rid="B92">Wilson et al., 1992</xref>), inhibition of Platelet-derived growth factor (PDGF) (<xref ref-type="bibr" rid="B39">Maguire et al., 1994</xref>), and anti-tuberculosis (<xref ref-type="bibr" rid="B36">Lilienkampf et al., 2009</xref>) agents. In other words, pyrrolidones are also typical buildings in several important categories of bioactive compounds (<xref ref-type="bibr" rid="B26">Jouyban et al., 2010</xref>; <xref ref-type="bibr" rid="B28">Kato and Nagao, 2012</xref>). Molecules bearing a pyrrolidone structure, are used in dye-sensitized solar cells and several natural products with biologically activeties (<xref ref-type="bibr" rid="B13">Daly et al., 1999</xref>; <xref ref-type="bibr" rid="B15">Dewick, 2009</xref>; <xref ref-type="bibr" rid="B21">Ikai et al., 2012</xref>). For instance, arcyria rubin A and its derivatives show potent antiviral activities (<xref ref-type="bibr" rid="B29">KIM et al., 1995</xref>; <xref ref-type="bibr" rid="B82">Slater et al., 1995</xref>), antimicrobial (<xref ref-type="bibr" rid="B41">Mahboobi et al., 2006</xref>), and powerful protein kinase C inhibitors (<xref ref-type="bibr" rid="B14">Davis et al., 1992</xref>).</p>
<p>The merger of these outstanding heterocycles, pyrrolidone, and quinolone is promising classes of pharmaceutical frameworks with antifungal (<xref ref-type="bibr" rid="B11">Chen et al., 2004</xref>), anti-inflammatory (<xref ref-type="bibr" rid="B27">Kategaonkar et al., 2010</xref>), anticancer (<xref ref-type="bibr" rid="B17">Eswaran et al., 2010</xref>), anti-tuberculosis (<xref ref-type="bibr" rid="B89">Tseng et al., 2010</xref>), anti-Alzheimer (<xref ref-type="bibr" rid="B88">Tseng et al., 2009</xref>), anti-HIV, anti-hypertension, and anticancer activities (<xref ref-type="bibr" rid="B6">Camps et al., 2009</xref>; <xref ref-type="bibr" rid="B78">Sharma et al., 2018</xref>). They also have inhibitory activities versus hepatitis C virus (HCV) polymerase (<xref ref-type="bibr" rid="B87">Thomas and Tallman, 1981</xref>; <xref ref-type="bibr" rid="B84">Summa et al., 2009</xref>), ADAMTS-5 (A disintegrin and metalloproteinase with thrombospondin motifs 5) and ADAMTS-4 (A disintegrin and metalloproteinase with thrombospondin motifs 4) (<xref ref-type="bibr" rid="B77">Sharma et al., 2008</xref>; <xref ref-type="bibr" rid="B7">Cappelli et al., 2010</xref>).</p>
<p>In this regard, the pyrrolo[3,4-c]quinoline-1,3-dione segment (<bold>1</bold>) exhibits a perfect range of pharmacologically and biologically enjoyable activities (<xref ref-type="fig" rid="F1">Figure 1</xref>) (<xref ref-type="bibr" rid="B55">Okun et al., 2006a</xref>; <xref ref-type="bibr" rid="B56">Okun et al., 2006b</xref>; <xref ref-type="bibr" rid="B76">Segura-Cabrera et al., 2011</xref>; <xref ref-type="bibr" rid="B51">Mollin et al., 2012</xref>). For example, pyrrolo[3,4-c]quinoline (<bold>2</bold>) is a potent inhibitor of caspase-3 (<xref ref-type="bibr" rid="B31">Kravchenko et al., 2005a</xref>), which plays a clef role in apoptosis (<xref ref-type="bibr" rid="B58">Porter and J&#xe4;nicke, 1999</xref>; <xref ref-type="bibr" rid="B18">Hentze et al., 2003</xref>). Caspases are interesting goals for therapeutic intervention in neurodegenerative, cardiovascular and metabolic disorders (<xref ref-type="bibr" rid="B38">Lockshin et al., 1998</xref>; <xref ref-type="bibr" rid="B37">Lockshin and Zakeri, 2004</xref>). In particular, caspase-3 inhibitors have been reported as powerful hepatoprotectants (<xref ref-type="bibr" rid="B38">Lockshin et al., 1998</xref>; <xref ref-type="bibr" rid="B19">Hoglen et al., 2001</xref>; <xref ref-type="bibr" rid="B75">Segawa et al., 2001</xref>; <xref ref-type="bibr" rid="B37">Lockshin and Zakeri, 2004</xref>; <xref ref-type="bibr" rid="B43">Meki et al., 2004</xref>), cardioprotectants (<xref ref-type="bibr" rid="B10">Chapman et al., 2002</xref>; <xref ref-type="bibr" rid="B24">Isabel et al., 2003</xref>), and neuroprotectants (<xref ref-type="bibr" rid="B73">Scott et al., 2003</xref>). Also, compound (<bold>3</bold>) has inhibitory activity against HCV polymerase (<xref ref-type="bibr" rid="B16">Di Francesco et al., 2009</xref>). Furthermore, alpkinidine (<bold>4</bold>) has shown potent therapeutic efficacy <italic>in vivo</italic> in HCT-116-bearing mice (<xref ref-type="bibr" rid="B90">Valeriote et al., 2012</xref>).</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>Bioactive pyrrolo[3,4-c]quinoline-2-ones.</p>
</caption>
<graphic xlink:href="fchem-11-1219986-g001.tif"/>
</fig>
<p>Because of broad applications in medicinal chemistry, the synthesis of these fused interesting heterocycles has specific importance to the pharmaceutical and organic chemists. Newly, there has been increasing attentiveness in the construction of pyrrole-fused-quinolines, and various procedures have been reported. Main synthetic approaches include Lewis acid-catalyzed electrophilic cyclization (<xref ref-type="bibr" rid="B1">Aggarwal et al., 2012</xref>), copper (<xref ref-type="bibr" rid="B30">Kiruthika et al., 2014</xref>) and palladium-catalyzed (<xref ref-type="bibr" rid="B8">Chai and Lautens, 2009</xref>; <xref ref-type="bibr" rid="B81">Shukla et al., 2012</xref>; <xref ref-type="bibr" rid="B30">Kiruthika et al., 2014</xref>) reactions, DDQ-mediated intramolecular cyclization (<xref ref-type="bibr" rid="B91">Wald et al., 1980</xref>), allene-based reaction cascades (<xref ref-type="bibr" rid="B4">Baumann and Baxendale, 2015</xref>), photo substituted reactions and flash vacuum pyrolysis. Although the majority of synthetic plans were applied for the synthesis of pyrrolo[3,2-c]quinoline and pyrrolo[1,2-a]quinoline analogs. Few synthetic relate have been released on the synthesis of pyrrolo[3,4-c]quinolones, and only multi-step synthetic methods are known to date.</p>
<p>In this matter, there are notable examples based on the cyclo condensation of b-keto amides and 2-amino-5-fluorophenyl glyoxylic acid (<xref ref-type="bibr" rid="B25">Ivachtchenko et al., 2003</xref>), Pfitzinger reaction (<xref ref-type="bibr" rid="B52">Mortoni et al., 2004</xref>; <xref ref-type="bibr" rid="B32">Kravchenko et al., 2005b</xref>), the one-pot two-component method by DMAP-catalyzed (<xref ref-type="bibr" rid="B3">Avula et al., 2013</xref>), the BF<sub>3</sub>Et<sub>2</sub>O-catalyzed isocyanide-based cycloaddition reaction (<xref ref-type="bibr" rid="B35">Li et al., 2013</xref>), and microwave-assisted reaction methods (<xref ref-type="bibr" rid="B93">Xia et al., 2014</xref>)<sup>,</sup> which all are multi-step reactions (<xref ref-type="scheme" rid="sch1">Scheme 1</xref>). However, these procedures are limited by low yields, harsh reaction conditions, the long reaction time, and their complexity.</p>
<fig id="sch1" position="float">
<label>SCHEME 1</label>
<caption>
<p>Multi-step; synthesis of pyrrolo[3,4-c]quinoline derivatives.</p>
</caption>
<graphic xlink:href="FCHEM_fchem-2023-1219986_wc_sch1.tif"/>
</fig>
<p>Multicomponent reactions (MCRs) have become increasingly popular as a simple and powerful tool for the rapid formation of new scaffolds from simple starting materials with structural diversity and molecular complexity in a convergent manner (<xref ref-type="bibr" rid="B42">Mashayekh and Shiri, 2019</xref>; <xref ref-type="bibr" rid="B74">Sedighian et al., 2021</xref>). MCRs are one-pot strategies exploiting three or more simple substrates where most of the reactant atoms are incorporated into the final desired product (<xref ref-type="bibr" rid="B12">Chen et al., 2017</xref>; <xref ref-type="bibr" rid="B33">Kurhade et al., 2019</xref>; <xref ref-type="bibr" rid="B79">Shiri and Aboonajmi, 2020</xref>; <xref ref-type="bibr" rid="B94">Yavari and Safaei, 2020</xref>). In comparison to the traditional multistep sequential assembly of target compounds, MCRs manifest several advantages including easy handling, selective bond formation, time-saving, high atom economy, fewer purification steps and structural variability (<xref ref-type="bibr" rid="B95">Younus et al., 2021</xref>; <xref ref-type="bibr" rid="B80">Shiri et al., 2022</xref>).</p>
<p>Due to our experience and interest in the synthesis of novel heterocycles, we became engrossed in how Knoevenagel product obtained from isatine and pyrazole could be <italic>in situ</italic> trapped by keto amides resulting from diketene and primary amines to give a heterocycle product. We considered the utilization of diketene as starting material and reagent because it is extensively used for the generation for a diverse range of different heterocycles. For this purpose, in continuation of our successive attempts towards the synthesis of heterocycles by multicomponent strategies, (<xref ref-type="bibr" rid="B60">Rezvanian et al., 2018a</xref>; <xref ref-type="bibr" rid="B86">Talaei et al., 2018</xref>; <xref ref-type="bibr" rid="B63">Rezvanian et al., 2020a</xref>; <xref ref-type="bibr" rid="B64">Rezvanian et al., 2020b</xref>), especially using diketene reactions (<xref ref-type="bibr" rid="B2">Alizadeh et al., 2012</xref>; <xref ref-type="bibr" rid="B70">Rezvanian, 2015</xref>; <xref ref-type="bibr" rid="B71">Rezvanian, 2016</xref>; <xref ref-type="bibr" rid="B59">Rezvanian et al., 2017</xref>; <xref ref-type="bibr" rid="B61">Rezvanian et al., 2018b</xref>; <xref ref-type="bibr" rid="B62">Rezvanian et al., 2019</xref>; <xref ref-type="bibr" rid="B65">Rezvanian et al., 2020c</xref>; <xref ref-type="bibr" rid="B66">Rezvanian et al., 2020d</xref>; <xref ref-type="bibr" rid="B67">Rezvanian et al., 2020e</xref>; <xref ref-type="bibr" rid="B68">Rezvanian et al., 2021a</xref>; <xref ref-type="bibr" rid="B69">Rezvanian et al., 2021b</xref>), we herein explain an efficient approach to synthesize pyrrolo[3,4-c]quinoline-1,3-diones <bold>7</bold> from the reaction of isatin, diketene, and primary amines based on the unique reactivity of pyrazole as a promoter in high yields (<xref ref-type="scheme" rid="sch3">Scheme 3</xref>).</p>
</sec>
<sec id="s2">
<title>2 Experimental section</title>
<sec id="s2-1">
<title>2.1 Instrumentation, analyses, and starting materials</title>
<p>The diketene, various amines, hydrazine, Hydrate, ethyl acetoacetate, and isatines were obtained from commercial sources with high purity. The <sup>1</sup>H NMR and <sup>13</sup>C NMR spectra were run on a Bruker spectrophotometer at 300/500 and 75/125&#xa0;MHz respectively. Coupling constants are reported in Hz. All mass spectra were measured on a mass spectrometer (Agilent5973 Network) at the ionization potential of 70 Ev. The IR spectra were recorded by BRUKER TENSOR 27 FT-IR instrument.</p>
</sec>
<sec id="s2-2">
<title>2.2 General procedure for the synthesis of 3-methyl-pyrazole-5-one</title>
<p>Hydrazine hydrate 70% (2&#xa0;mmol) was added to ethyl acetoacetate (1.4&#xa0;mmol) and was treated at room temperature without solvent. After 30&#xa0;min, the product was precipitate and filtered, and washed with a few drops of water, and pyrazole was obtained as a white crystal dried and used for further steps.</p>
</sec>
<sec id="s2-3">
<title>2.3 General procedure for the synthesis of structurally diverse pyrrolo[3,4-c]quinoline-1,3-diones 7</title>
<p>To a round-bottom flask (25&#xa0;mL), the following were added; pyrazole (1.0&#xa0;mmol), isatin <bold>5</bold> (1.0&#xa0;mmol), diketene (1.0&#xa0;mmol), primary amine <bold>6</bold> (1.0&#xa0;mmol); and the reaction mixture was stirred at reflux for approximately 4&#xa0;h and monitored by TLC until the substrates were wholly consumed. Upon the formation of the desired product <bold>7</bold>, the product was precipitated, filtered, and washed with a few drops of EtOH, and the target compound <bold>7</bold> was obtained as a yellow solid with excellent yield (73%&#x2013;90%). Post separating product <bold>7</bold>, the reaction mixture was cooled to 20&#xb0;C&#x2013;25&#xb0;C, and upon cooling the reaction mixture and evaporation of the solvent, the sediment solid was filtered and washed with ethanol, and finally the pyrazole was obtained again with 81% yield.</p>
</sec>
</sec>
<sec sec-type="results|discussion" id="s3">
<title>3 Results and discussion</title>
<p>At the outset of our investigation, the reaction of hydrazine, ethyl acetoacetate, isatine <bold>5</bold>, diketene, and primary amine <bold>6</bold> in the lack of any catalyst at room temperature was designed. To study this new process, isatin <bold>5a</bold>, ethyl amine <bold>6a</bold>, and ethyl acetoacetate were selected as model reactions (<xref ref-type="scheme" rid="sch2">Scheme 2</xref>). In this route, firstly, hydrazine (1&#xa0;mmol), ethyl acetoacetate (1&#xa0;mmol), and isatin <bold>5a</bold> (1&#xa0;mmol) in ethanol (4&#xa0;ml) were stirred at room temperature for 1&#xa0;h, which afforded the Michael adduct <bold>8a</bold>. Next, ethylamine <bold>6a</bold> (1&#xa0;mmol) and diketene (1&#xa0;mmol) were added to the reaction mixture. The advance of the reaction was followed by TLC (1-6 ethyl acetate-hexane). Unfortunately, no product was obtained at room temperature after 48&#xa0;h (<xref ref-type="table" rid="T1">Table 1</xref>, entries 1). However, when the mixture reaction was heated at 70&#xb0;C gratifyingly, we observed that the acceptable product was formed in an isolated yield of 84% within 5&#xa0;h (<xref ref-type="table" rid="T1">Table 1</xref>, entry 2). Upon the construction of the desired outcome, immediately the precipitated solid was filtered off, washed with ethanol, and crystallized from hot ethanol in excellent yield. Amazingly, instead of the expected spiro pyridine product <bold>11</bold> (<xref ref-type="scheme" rid="sch4">Scheme 4</xref>), we observed an unanticipated process leading to pyrrolo[3,4-c]quinolone <bold>7a</bold> in excellent yield (<xref ref-type="scheme" rid="sch2">Scheme 2</xref>). On the other hand, post-workup product <bold>7a</bold>, the solvent was evaporated. We observed the precipitated white solid of pyrazole (from hydrazine and ethyl acetoacetate) slowly settling in which it was filtered and washed with water. The absolute structure of the newly synthesized product <bold>7a</bold> was explicitly confirmed by X-ray analysis.</p>
<fig id="sch2" position="float">
<label>SCHEME 2</label>
<caption>
<p>Synthesis of pyrrolo[3,4-c]quinoline-1,2-dione <bold>7a</bold>.</p>
</caption>
<graphic xlink:href="FCHEM_fchem-2023-1219986_wc_sch2.tif"/>
</fig>
<table-wrap id="T1" position="float">
<label>TABLE 1</label>
<caption>
<p>Examining; optimum reaction conditions.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th colspan="5" align="center">
<inline-graphic xlink:href="FCHEM_fchem-2023-1219986_wc_tfx1.tif"/>
</th>
</tr>
<tr>
<th align="center">Entry</th>
<th align="center">Solvent</th>
<th align="center">Temp. (&#x2da;C)</th>
<th align="center">Time (h)</th>
<th align="center">Yield (%)<sup>b</sup>
</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="center">1</td>
<td align="center">Ethanol (4&#xa0;mL)</td>
<td align="center">r.t.</td>
<td align="center">48</td>
<td align="center">-</td>
</tr>
<tr>
<td align="center">2</td>
<td align="center">Ethanol (4&#xa0;mL)</td>
<td align="center">70</td>
<td align="center">4</td>
<td align="center">90</td>
</tr>
<tr>
<td align="center">3</td>
<td align="center">Ethanol (4&#xa0;mL)</td>
<td align="center">80</td>
<td align="center">4</td>
<td align="center">90</td>
</tr>
<tr>
<td align="center">4</td>
<td align="center">Acetonitrile (4&#xa0;mL)</td>
<td align="center">70</td>
<td align="center">12</td>
<td align="center">45</td>
</tr>
<tr>
<td align="center">5</td>
<td align="center">Methanol (4&#xa0;mL)</td>
<td align="center">70</td>
<td align="center">8</td>
<td align="center">33</td>
</tr>
<tr>
<td align="center">6</td>
<td align="center">Water (4&#xa0;mL)</td>
<td align="center">70</td>
<td align="center">8</td>
<td align="center">52</td>
</tr>
<tr>
<td align="center">7</td>
<td align="center">Water/ethanol (4&#xa0;mL)</td>
<td align="center">70</td>
<td align="center">5</td>
<td align="center">60</td>
</tr>
<tr>
<td align="center">8</td>
<td align="center">Tetrahydrofuran(4&#xa0;mL)</td>
<td align="center">70</td>
<td align="center">12</td>
<td align="center">30</td>
</tr>
</tbody>
</table>
</table-wrap>
<p>Then, in a controlled testing, the reaction of this five-component manufacturing process proceeds in the absence of pyrazole resulting from hydrazine and ethyl acetoacetate in which the effect of pyrazole was evaluated for this reaction. We concluded that the response could not advance without pyrazole under these conditions, and when the reaction mixture was carried with pyrazole (1&#xa0;mol), the objective compound <bold>7a</bold> obtained an 84% yield. Also, the change in amounts of pyrazole was explored for the reaction. The best result (90%) of the product was formed when (1&#xa0;mol) of the pyrazole was exploited. By decreasing the amount of pyrazole to (0.7 and 0.5&#xa0;mol), the development was accomplished at 35% and 27%, and it was observed that increasing the pyrazole loading had a considerable effect on the formation product. However, without using pyrazole, the reaction failed to develop even after 48&#xa0;h.</p>
<p>Thus, to increase the yield of pyrrolo[3,4-c]quinoline-1,3-dione <bold>7a</bold> and minimize reaction time, four-component reactions between isatin <bold>5a</bold>, pyrazole, diketene, and ethylamine <bold>6a</bold> were designed (<xref ref-type="table" rid="T1">Table 1</xref>), because of the success achieved using pyrazole promoted response. We found pyrrolo[3,4-c]quinoline-1,3-dione 7a as the only product when the reaction mixture was composed of a 1:1:1:1 variety of compounds.</p>
<p>In this reaction, solvent and temperature were examined to optimize the reaction conditions. Due; to the impossibility of carrying out the reaction at ambient temperature, the response was performed under reflux conditions. Also, it was observed that increasing the temperature above 70&#xb0;C has no significant effect on the product yield. Despite obtaining good results, organic solvents did not improve much compared to water, including acetonitrile, methanol, water, water/ethanol, and tetrahydrofuran). Therefore, all reactions were performed under reflux conditions at 70&#xb0;C in water to give satisfactory and excellent results.</p>
<p>Reaction conditions: pyrazole (1.0&#xa0;mmol), isatine <bold>5a</bold> (1.0&#xa0;mmol), diketene (1.0&#xa0;mmol), ethyl amine <bold>6a</bold> (1.0&#xa0;mmol), solvent (4.0&#xa0;ml). [b] Isolated yield.</p>
<p>Having identified the best available conditions, to explore the efficiency and generality of this approach, the reactions between another isatine <bold>1</bold> and primary amines <bold>2</bold> were conducted, and the outcomes are shown in <xref ref-type="scheme" rid="sch3">Scheme 3</xref>. The corresponding functionalized pyrrolo[3,4-c]quinoline-1,3-diones <bold>7</bold> were obtained in excellent yields at 70&#xb0;C in ethanol in the presence of pyrazole (1&#xa0;mmol) as a promoter. Various primary amines (<bold>6a-f</bold>) reacted with isatines to generate corresponding pyrrolo[3,4-c]quinoline-1,3-diones <bold>7a-h</bold>.</p>
<fig id="sch3" position="float">
<label>SCHEME 3</label>
<caption>
<p>Scope; of the reaction.<sup>a,b</sup>.<sup>a</sup>[a] The reaction was performed at 70&#xb0;C with 1 equivalent of substrates. [b] The new pyrrolo[3,4-c]quinoline-1,3-diones were afforded (see the Supporting Information).</p>
</caption>
<graphic xlink:href="FCHEM_fchem-2023-1219986_wc_sch3.tif"/>
</fig>
<p>The skeleton of all synthetic compounds <bold>7a-h</bold> was elucidated by ESI-MS, IR, <sup>1</sup>HNMR, <sup>13</sup>CNMR spectroscopy, and X-ray analysis. FTIR of <bold>7a</bold> exhibited absorption bands in 1764, 1705, and 1622 due to the two CO and C&#x3d;N stretching frequencies. In the <sup>1</sup>H-NMR spectrum of <bold>7a</bold>, triplet and quartet in <italic>&#x3b4;</italic> &#x3d; 1.31 (<sup>3</sup>
<italic>J</italic>
<sub>H-H</sub> &#x3d; 7.2&#xa0;Hz) and <italic>&#x3b4;</italic> &#x3d; 3.77 (<sup>3</sup>
<italic>J</italic>
<sub>H-H</sub> &#x3d; 7.2&#xa0;Hz) ppm are due to CH<sub>3</sub> and CH<sub>2</sub> groups. The Singlet peak in <italic>&#x3b4;</italic> &#x3d; 3.01 is due to the CH<sub>3</sub> group. Also the signals in the aromatic section confirmed the presence of the four aromatic hydrogens of the aromatic ring. The presence of 14 apparent signs in the <sup>13</sup>C-NMR spectrum is in accordance with the suggested structure of <bold>7a</bold>. The highlighted areas in the <sup>13</sup>C NMR are due to two CH<sub>3</sub>, two CH<sub>2</sub>, and two&#xa0;C&#x3d;O groups, which are evident at <italic>&#x3b4;</italic> &#x3d; 13.94, 22.03, 33.01, 168.06, 168.33&#xa0;ppm. Single crystal X-ray crystallography structure of <bold>7b</bold> was certified as the product structure (<xref ref-type="fig" rid="F2">Figure 2</xref>).</p>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption>
<p>ORTEP; diagram of <bold>7b</bold>.</p>
</caption>
<graphic xlink:href="fchem-11-1219986-g002.tif"/>
</fig>
<p>This reaction is a particular case, and a probable tool is illustrated in <xref ref-type="scheme" rid="sch4">Scheme 4</xref> for the generation of compound <bold>7</bold>. It is advisable to suggest that the first stage starts via a Knoevenagel-type condensation of isatine and pyrazole to provide the intermediate <bold>8</bold> as the Michael acceptor. Then, nucleophilic attack of the amine to diketene and ring-opening of diketene pursue by proton transfer to give <italic>&#x3b2;</italic>-ketoamide <bold>9.</bold> After the formation of adduct <bold>8</bold>, nucleophilic addition enol form <bold>10</bold> on the Michael acceptor <bold>8</bold> afforded intermediate <bold>11</bold> <italic>via</italic> Michael addition. At this stage, attending to the preceding articles, we expected adduct <bold>11</bold> with <italic>O</italic>-cyclization, attacking the carbonyl group, and tautomerization to give the desired heterocyclic compound <bold>13</bold>. But contemplating X-ray diffraction and <sup>1</sup>H and <sup>13</sup>C NMR spectra, product <bold>12</bold> was not formed, and another extraordinary incident happened. In truth, in this step, nucleophilic addition of the enol form <bold>10</bold> is followed the elimination of pyrazole to give <bold>14</bold> via proton transfer. Then, in intermediate <bold>14</bold>, with an intramolecular cyclization via <italic>N</italic>-nucleophilic attack of the amide group and proton transfer to form middle <bold>15</bold>, ring opening and proton transfer gives the medium <bold>17</bold>. Finally, nucleophilic attack of the amine <bold>17</bold> to C&#x3d;O bond, intramolecular cyclization to form middle <bold>18,</bold> elimination of H<sub>2</sub>O, and deprotonation product <bold>7</bold> are created.</p>
<fig id="sch4" position="float">
<label>SCHEME 4</label>
<caption>
<p>A plausible mechanism for the formation of the product <bold>7</bold>.</p>
</caption>
<graphic xlink:href="FCHEM_fchem-2023-1219986_wc_sch4.tif"/>
</fig>
</sec>
<sec sec-type="conclusion" id="s4">
<title>4 Conclusion</title>
<p>As a result, we have described an unusual three-component reaction to construct novel molecules containing a pyrrolo[3,4-c]quinoline-1,3-dione core from readily available reagents of pyrazole, isatine, diketene, and primary amine in ethanol. The most significant aspects of the process are the accessibility of the starting precursors, mild reaction conditions, short reaction times, high yields of the synthesized products, and easy operation at the manufacturing scale. The overall process of reaction includes all the aspects of green chemistry and has new portals for the growth of more sustainable multicomponent reactions. This category of heterocycles with several pharmacophores may be interesting for medicine and pharmacology.</p>
</sec>
</body>
<back>
<sec sec-type="data-availability" id="s5">
<title>Data availability statement</title>
<p>Detailed experimental procedures and compound characterization data in the Supporting Information (PDF) are available. X-ray Crystallography: Deposition Number 7a is 2202802c and contains the supplementary crystallographic data for this paper. <ext-link ext-link-type="uri" xlink:href="http://www.ccdc.cam.ac.uk/structures">www.ccdc.cam.ac.uk/structures</ext-link>.</p>
</sec>
<sec id="s6">
<title>Author contributions</title>
<p>AR analyzed spectral characterization of synthesized molecules. AR wrote and edited the article. All authors contributed to the article and approved the submitted version.</p>
</sec>
<ack>
<p>Financial support from the Research Council of Alzahra University is sincerely acknowledged.</p>
</ack>
<sec sec-type="COI-statement" id="s7">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="disclaimer" id="s8">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<sec id="s9">
<title>Supplementary material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fchem.2023.1219986/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fchem.2023.1219986/full&#x23;supplementary-material</ext-link>
</p>
<supplementary-material xlink:href="DataSheet1.docx" id="SM1" mimetype="application/docx" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aggarwal</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Kumar</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Dhaked</surname>
<given-names>D. K.</given-names>
</name>
<name>
<surname>Tiwari</surname>
<given-names>R. K.</given-names>
</name>
<name>
<surname>Bharatam</surname>
<given-names>P. V.</given-names>
</name>
<name>
<surname>Verma</surname>
<given-names>A. K.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Site-selective electrophilic cyclization and subsequent ring-opening: A synthetic route to pyrrolo [1, 2-a] quinolines and indolizines</article-title>. <source>J. Org. Chem.</source> <volume>77</volume> (<issue>19</issue>), <fpage>8562</fpage>&#x2013;<lpage>8573</lpage>. <pub-id pub-id-type="doi">10.1021/jo3015374</pub-id>
</citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Alizadeh</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Rezvanian</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>L. G.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Synthesis of heterocyclic [3.3. 3] propellanes via a sequential four-component reaction</article-title>. <source>J. Org. Chem.</source> <volume>77</volume> (<issue>9</issue>), <fpage>4385</fpage>&#x2013;<lpage>4390</lpage>. <pub-id pub-id-type="doi">10.1021/jo300457m</pub-id>
</citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Avula</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Koppireddi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Komsani</surname>
<given-names>J. R.</given-names>
</name>
<name>
<surname>Nanubolu</surname>
<given-names>J. B.</given-names>
</name>
<name>
<surname>Yadla</surname>
<given-names>R.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>One-pot two-component tandem multiple transformations in the synthesis of N, 4-diaryl-2, 3-dihydropyrrolo [3, 4-c] quinolin-1, 3-diones and their 3-thioxo-analogues under neat conditions</article-title>. <source>RSC Adv.</source> <volume>3</volume> (<issue>43</issue>), <fpage>20990</fpage>&#x2013;<lpage>20998</lpage>. <pub-id pub-id-type="doi">10.1039/c3ra43489c</pub-id>
</citation>
</ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Baumann</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Baxendale</surname>
<given-names>I. R.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Batch and flow synthesis of pyrrolo [1, 2-a]-quinolines via an allene-based reaction cascade</article-title>. <source>J. Org. Chem.</source> <volume>80</volume> (<issue>21</issue>), <fpage>10806</fpage>&#x2013;<lpage>10816</lpage>. <pub-id pub-id-type="doi">10.1021/acs.joc.5b01982</pub-id>
</citation>
</ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cai</surname>
<given-names>X. H.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Su</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y. P.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>X. N.</given-names>
</name>
<name>
<surname>Luo</surname>
<given-names>X. D.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Novel indole and quinoline alkaloids from Melodinus yunnanensis</article-title>. <source>Nat. Prod. bioprospecting</source> <volume>1</volume> (<issue>1</issue>), <fpage>25</fpage>&#x2013;<lpage>28</lpage>. <pub-id pub-id-type="doi">10.1007/s13659-011-0001-0</pub-id>
</citation>
</ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Camps</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Formosa</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Galdeano</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Munoz-Torrero</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Ram&#xed;rez</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>G&#xf3;mez</surname>
<given-names>E.</given-names>
</name>
<etal/>
</person-group> (<year>2009</year>). <article-title>Pyrano [3, 2-c] quinoline&#x2212; 6-chlorotacrine hybrids as a novel family of acetylcholinesterase-and &#x3b2;-amyloid-directed anti-Alzheimer compounds</article-title>. <source>J. Med. Chem.</source> <volume>52</volume> (<issue>17</issue>), <fpage>5365</fpage>&#x2013;<lpage>5379</lpage>. <pub-id pub-id-type="doi">10.1021/jm900859q</pub-id>
</citation>
</ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cappelli</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Nannicini</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Valenti</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Giuliani</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Anzini</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Mennuni</surname>
<given-names>L.</given-names>
</name>
<etal/>
</person-group> (<year>2010</year>). <article-title>Design, synthesis, and preliminary biological evaluation of pyrrolo [3, 4&#x2010;c] quinolin&#x2010;1&#x2010;one and oxoisoindoline derivatives as aggrecanase inhibitors</article-title>. <source>ChemMedChem</source> <volume>5</volume> (<issue>5</issue>), <fpage>739</fpage>&#x2013;<lpage>748</lpage>. <pub-id pub-id-type="doi">10.1002/cmdc.200900523</pub-id>
</citation>
</ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chai</surname>
<given-names>D. I.</given-names>
</name>
<name>
<surname>Lautens</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Tandem Pd-catalyzed double C&#x2212; C bond formation: Effect of water</article-title>. <source>J. Org. Chem.</source> <volume>74</volume> (<issue>8</issue>), <fpage>3054</fpage>&#x2013;<lpage>3061</lpage>. <pub-id pub-id-type="doi">10.1021/jo900053b</pub-id>
</citation>
</ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chamulitrat</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Pathil</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Setchell</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Stremmel</surname>
<given-names>W.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Hepatoprotectant ursodeoxycholyl lysophosphatidylethanolamide increasing phosphatidylcholine levels as a potential therapy of acute liver injury</article-title>. <source>Front. Physiology</source> <volume>3</volume>, <fpage>24</fpage>. <pub-id pub-id-type="doi">10.3389/fphys.2012.00024</pub-id>
</citation>
</ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chapman</surname>
<given-names>J. G.</given-names>
</name>
<name>
<surname>Magee</surname>
<given-names>W. P.</given-names>
</name>
<name>
<surname>Stukenbrok</surname>
<given-names>H. A.</given-names>
</name>
<name>
<surname>Beckius</surname>
<given-names>G. E.</given-names>
</name>
<name>
<surname>Milici</surname>
<given-names>A. J.</given-names>
</name>
<name>
<surname>Tracey</surname>
<given-names>W. R.</given-names>
</name>
</person-group> (<year>2002</year>). <article-title>A novel nonpeptidic caspase-3/7 inhibitor,(S)-(&#x2b;)-5-[1-(2-methoxymethylpyrrolidinyl) sulfonyl] isatin reduces myocardial ischemic injury</article-title>. <source>Eur. J. Pharmacol.</source> <volume>456</volume> (<issue>1-3</issue>), <fpage>59</fpage>&#x2013;<lpage>68</lpage>. <pub-id pub-id-type="doi">10.1016/s0014-2999(02)02484-6</pub-id>
</citation>
</ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>Y. L.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>I. L.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>C. M.</given-names>
</name>
<name>
<surname>Tzeng</surname>
<given-names>C. C.</given-names>
</name>
<name>
<surname>Tsao</surname>
<given-names>L. T.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J. P.</given-names>
</name>
</person-group> (<year>2004</year>). <article-title>Synthesis and anti-inflammatory evaluation of 4-anilinofuro [2, 3-b] quinoline and 4-phenoxyfuro [2, 3-b] quinoline derivatives. Part 3</article-title>. <source>Bioorg. Med. Chem.</source> <volume>12</volume> (<issue>2</issue>), <fpage>387</fpage>&#x2013;<lpage>392</lpage>. <pub-id pub-id-type="doi">10.1016/j.bmc.2003.10.051</pub-id>
</citation>
</ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Cao</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Ren</surname>
<given-names>H.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Recent advances in multicomponent synthesis of 1, 4, 5&#x2010;trisubstituted 1, 2, 3&#x2010;triazoles</article-title>. <source>Adv. Synthesis Catal.</source> <volume>359</volume> (<issue>2</issue>), <fpage>202</fpage>&#x2013;<lpage>224</lpage>. <pub-id pub-id-type="doi">10.1002/adsc.201600918</pub-id>
</citation>
</ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Daly</surname>
<given-names>J. W.</given-names>
</name>
<name>
<surname>Garraffo</surname>
<given-names>H. M.</given-names>
</name>
<name>
<surname>Spande</surname>
<given-names>T. F.</given-names>
</name>
</person-group> (<year>1999</year>). <article-title>Alkaloids from amphibian skins</article-title>. <source>Alkaloids Chem. Biol. Perspect.</source> <volume>13</volume>, <fpage>1</fpage>&#x2013;<lpage>161</lpage>.</citation>
</ref>
<ref id="B14">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Davis</surname>
<given-names>P. D.</given-names>
</name>
<name>
<surname>Hill</surname>
<given-names>C. H.</given-names>
</name>
<name>
<surname>Lawton</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Nixon</surname>
<given-names>J. S.</given-names>
</name>
<name>
<surname>Wilkinson</surname>
<given-names>S. E.</given-names>
</name>
<name>
<surname>Hurst</surname>
<given-names>S. A.</given-names>
</name>
<etal/>
</person-group> (<year>1992</year>). <article-title>Inhibitors of protein kinase C. 1. 2, 3-Bisarylmaleimides</article-title>. <source>J. Med. Chem.</source> <volume>35</volume> (<issue>1</issue>), <fpage>177</fpage>&#x2013;<lpage>184</lpage>. <pub-id pub-id-type="doi">10.1021/jm00079a024</pub-id>
</citation>
</ref>
<ref id="B15">
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Dewick</surname>
<given-names>P. M.</given-names>
</name>
</person-group> (<year>2009</year>). <source>Medicinal natural products: A biosynthetic approach</source>. <edition>3</edition>. <publisher-loc>Chichester, U.K.</publisher-loc>: <publisher-name>John Wiley &#x26; Sons</publisher-name>. <comment>Chapter 6 and references therein</comment>.</citation>
</ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Di Francesco</surname>
<given-names>M. E.</given-names>
</name>
<name>
<surname>Dessole</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Nizi</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Pace</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Koch</surname>
<given-names>U.</given-names>
</name>
<name>
<surname>Fiore</surname>
<given-names>F.</given-names>
</name>
<etal/>
</person-group> (<year>2009</year>). <article-title>Novel macrocyclic inhibitors of hepatitis C NS3/4A protease featuring a 2-amino-1, 3-thiazole as a P4 carbamate replacement</article-title>. <source>J. Med. Chem.</source> <volume>52</volume> (<issue>22</issue>), <fpage>7014</fpage>&#x2013;<lpage>7028</lpage>. <pub-id pub-id-type="doi">10.1021/jm900524b</pub-id>
</citation>
</ref>
<ref id="B17">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Eswaran</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Adhikari</surname>
<given-names>A. V.</given-names>
</name>
<name>
<surname>Kumar</surname>
<given-names>R. A.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>New 1, 3-oxazolo [4, 5-c] quinoline derivatives: Synthesis and evaluation of antibacterial and antituberculosis properties</article-title>. <source>Eur. J. Med. Chem.</source> <volume>45</volume> (<issue>3</issue>), <fpage>957</fpage>&#x2013;<lpage>966</lpage>. <pub-id pub-id-type="doi">10.1016/j.ejmech.2009.11.036</pub-id>
</citation>
</ref>
<ref id="B18">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hentze</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>X. Y.</given-names>
</name>
<name>
<surname>Choi</surname>
<given-names>M. S. K.</given-names>
</name>
<name>
<surname>Porter</surname>
<given-names>A. G.</given-names>
</name>
</person-group> (<year>2003</year>). <article-title>Critical role for cathepsin B in mediating caspase-1-dependent interleukin-18 maturation and caspase-1-independent necrosis triggered by the microbial toxin nigericin</article-title>. <source>Cell. Death Differ.</source> <volume>10</volume> (<issue>9</issue>), <fpage>956</fpage>&#x2013;<lpage>968</lpage>. <pub-id pub-id-type="doi">10.1038/sj.cdd.4401264</pub-id>
</citation>
</ref>
<ref id="B19">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hoglen</surname>
<given-names>N. C.</given-names>
</name>
<name>
<surname>Hirakawa</surname>
<given-names>B. P.</given-names>
</name>
<name>
<surname>Fisher</surname>
<given-names>C. D.</given-names>
</name>
<name>
<surname>Weeks</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Srinivasan</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Wong</surname>
<given-names>A. M.</given-names>
</name>
<etal/>
</person-group> (<year>2001</year>). <article-title>Characterization of the caspase inhibitor IDN-1965 in a model of apoptosis-associated liver injury</article-title>. <source>J. Pharmacol. Exp. Ther.</source> <volume>297</volume> (<issue>2</issue>), <fpage>811</fpage>&#x2013;<lpage>818</lpage>.</citation>
</ref>
<ref id="B20">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hulcoop</surname>
<given-names>D. G.</given-names>
</name>
<name>
<surname>Lautens</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2007</year>). <article-title>Palladium-catalyzed annulation of aryl heterocycles with strained alkenes</article-title>. <source>Org. Lett.</source> <volume>9</volume> (<issue>9</issue>), <fpage>1761</fpage>&#x2013;<lpage>1764</lpage>. <pub-id pub-id-type="doi">10.1021/ol070475w</pub-id>
</citation>
</ref>
<ref id="B21">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ikai</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Azam</surname>
<given-names>A. F.</given-names>
</name>
<name>
<surname>Kuzuba</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kuwabara</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Maeda</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Takahashi</surname>
<given-names>K.</given-names>
</name>
<etal/>
</person-group> (<year>2012</year>). <article-title>Synthesis of seleno [3, 4-c] pyrrole-4, 6-dione-based polymers for polymer solar cells</article-title>. <source>Synth. Met.</source> <volume>162</volume> (<issue>17-18</issue>), <fpage>1707</fpage>&#x2013;<lpage>1712</lpage>. <pub-id pub-id-type="doi">10.1016/j.synthmet.2012.07.003</pub-id>
</citation>
</ref>
<ref id="B22">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Insuasty</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Montoya</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Becerra</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Quiroga</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Abonia</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Robledo</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2013</year>). <article-title>Synthesis of novel analogs of 2-pyrazoline obtained from [(7-chloroquinolin-4-yl) amino] chalcones and hydrazine as potential antitumor and antimalarial agents</article-title>. <source>Eur. J. Med. Chem.</source> <volume>67</volume>, <fpage>252</fpage>&#x2013;<lpage>262</lpage>. <pub-id pub-id-type="doi">10.1016/j.ejmech.2013.06.049</pub-id>
</citation>
</ref>
<ref id="B23">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Isaac-M&#xe1;rquez</surname>
<given-names>A. P.</given-names>
</name>
<name>
<surname>McChesney</surname>
<given-names>J. D.</given-names>
</name>
<name>
<surname>Nanayakara</surname>
<given-names>N. D.</given-names>
</name>
<name>
<surname>Satoskar</surname>
<given-names>A. R.</given-names>
</name>
<name>
<surname>Lezama-D&#xe1;vila</surname>
<given-names>C. M.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Leishmanicidal activity of racemic&#xb1;8-[(4-Amino-1-methylbutyl) amino]-6-methoxy-4-methyl-5-[3, 4-dichlorophenoxy] quinoline</article-title>. <source>Nat. Product. Commun.</source> <volume>5</volume> (<issue>3</issue>), <fpage>1934578X1000500</fpage>. <pub-id pub-id-type="doi">10.1177/1934578x1000500309</pub-id>
</citation>
</ref>
<ref id="B24">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Isabel</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Black</surname>
<given-names>W. C.</given-names>
</name>
<name>
<surname>Bayly</surname>
<given-names>C. I.</given-names>
</name>
<name>
<surname>Grimm</surname>
<given-names>E. L.</given-names>
</name>
<name>
<surname>Janes</surname>
<given-names>M. K.</given-names>
</name>
<name>
<surname>McKay</surname>
<given-names>D. J.</given-names>
</name>
<etal/>
</person-group> (<year>2003</year>). <article-title>Nicotinyl aspartyl ketones as inhibitors of caspase-3</article-title>. <source>Bioorg. Med. Chem. Lett.</source> <volume>13</volume> (<issue>13</issue>), <fpage>2137</fpage>&#x2013;<lpage>2140</lpage>. <pub-id pub-id-type="doi">10.1016/s0960-894x(03)00390-1</pub-id>
</citation>
</ref>
<ref id="B25">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ivachtchenko</surname>
<given-names>A. V.</given-names>
</name>
<name>
<surname>Kobak</surname>
<given-names>V. V.</given-names>
</name>
<name>
<surname>Il&#x27;yin</surname>
<given-names>A. P.</given-names>
</name>
<name>
<surname>Trifilenkov</surname>
<given-names>A. S.</given-names>
</name>
<name>
<surname>Busel</surname>
<given-names>A. A.</given-names>
</name>
</person-group> (<year>2003</year>). <article-title>New scaffolds for combinatorial synthesis. II. 6-sulfamoylquinolinecarboxylic acids</article-title>. <source>J. Comb. Chem.</source> <volume>5</volume> (<issue>5</issue>), <fpage>645</fpage>&#x2013;<lpage>652</lpage>. <pub-id pub-id-type="doi">10.1021/cc020090z</pub-id>
</citation>
</ref>
<ref id="B26">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jouyban</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Fakhree</surname>
<given-names>M. A. A.</given-names>
</name>
<name>
<surname>Shayanfar</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Review of pharmaceutical applications of N-methyl-2-pyrrolidone</article-title>. <source>J. Pharm. Pharm. Sci.</source> <volume>13</volume> (<issue>4</issue>), <fpage>524</fpage>&#x2013;<lpage>535</lpage>. <pub-id pub-id-type="doi">10.18433/j3p306</pub-id>
</citation>
</ref>
<ref id="B27">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kategaonkar</surname>
<given-names>A. H.</given-names>
</name>
<name>
<surname>Pokalwar</surname>
<given-names>R. U.</given-names>
</name>
<name>
<surname>Sonar</surname>
<given-names>S. S.</given-names>
</name>
<name>
<surname>Gawali</surname>
<given-names>V. U.</given-names>
</name>
<name>
<surname>Shingate</surname>
<given-names>B. B.</given-names>
</name>
<name>
<surname>Shingare</surname>
<given-names>M. S.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Synthesis, <italic>in vitro</italic> antibacterial and antifungal evaluations of new &#x3b1;-hydroxyphosphonate and new &#x3b1;-acetoxyphosphonate derivatives of tetrazolo [1, 5-a] quinoline</article-title>. <source>Eur. J. Med. Chem.</source> <volume>45</volume> (<issue>3</issue>), <fpage>1128</fpage>&#x2013;<lpage>1132</lpage>. <pub-id pub-id-type="doi">10.1016/j.ejmech.2009.12.013</pub-id>
</citation>
</ref>
<ref id="B28">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kato</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Nagao</surname>
<given-names>Y.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Effect of polyvinylpyrrolidone on sperm function and early embryonic development following intracytoplasmic sperm injection in human assisted reproduction</article-title>. <source>Reproductive Med. Biol.</source> <volume>11</volume> (<issue>4</issue>), <fpage>165</fpage>&#x2013;<lpage>176</lpage>. <pub-id pub-id-type="doi">10.1007/s12522-012-0126-9</pub-id>
</citation>
</ref>
<ref id="B29">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Sagara</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>KawAI</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>1995</year>). <article-title>Studies on the antiviral activity of protein kinase inhibitors against the replication of vesicular stomatitis virus</article-title>. <source>Biol. Pharm. Bull.</source> <volume>18</volume> (<issue>6</issue>), <fpage>895</fpage>&#x2013;<lpage>899</lpage>. <pub-id pub-id-type="doi">10.1248/bpb.18.895</pub-id>
</citation>
</ref>
<ref id="B30">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kiruthika</surname>
<given-names>S. E.</given-names>
</name>
<name>
<surname>Nandakumar</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Perumal</surname>
<given-names>P. T.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Synthesis of pyrrolo-/indolo [1, 2-a] quinolines and naphtho [2, 1-b] thiophenes from gem-dibromovinyls and sulphonamides</article-title>. <source>Org. Lett.</source> <volume>16</volume> (<issue>17</issue>), <fpage>4424</fpage>&#x2013;<lpage>4427</lpage>. <pub-id pub-id-type="doi">10.1021/ol5019085</pub-id>
</citation>
</ref>
<ref id="B31">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kravchenko</surname>
<given-names>D. V.</given-names>
</name>
<name>
<surname>Kysil</surname>
<given-names>V. M.</given-names>
</name>
<name>
<surname>Tkachenko</surname>
<given-names>S. E.</given-names>
</name>
<name>
<surname>Maliarchouk</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Okun</surname>
<given-names>I. M.</given-names>
</name>
<name>
<surname>Ivachtchenko</surname>
<given-names>A. V.</given-names>
</name>
</person-group> (<year>2005a</year>). <article-title>Pyrrolo [3, 4-c] quinoline-1, 3-diones as potent caspase-3 inhibitors. Synthesis and SAR of 2-substituted 4-methyl-8-(morpholine-4-sulfonyl)-pyrrolo [3, 4-c] quinoline-1, 3-diones</article-title>. <source>Eur. J. Med. Chem.</source> <volume>40</volume> (<issue>12</issue>), <fpage>1377</fpage>&#x2013;<lpage>1383</lpage>. <pub-id pub-id-type="doi">10.1016/j.ejmech.2005.07.011</pub-id>
</citation>
</ref>
<ref id="B32">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kravchenko</surname>
<given-names>D. V.</given-names>
</name>
<name>
<surname>Kysil</surname>
<given-names>V. M.</given-names>
</name>
<name>
<surname>Tkachenko</surname>
<given-names>S. E.</given-names>
</name>
<name>
<surname>Maliarchouk</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Okun</surname>
<given-names>I. M.</given-names>
</name>
<name>
<surname>Ivachtchenko</surname>
<given-names>A. V.</given-names>
</name>
</person-group> (<year>2005b</year>). <article-title>Synthesis and caspase-3 inhibitory activity of 8-sulfonyl-1, 3-dioxo-2, 3-dihydro-1H-pyrrolo [3, 4-c] quinolines</article-title>. <source>Il F&#xe1;rmaco</source> <volume>60</volume> (<issue>10</issue>), <fpage>804</fpage>&#x2013;<lpage>809</lpage>. <pub-id pub-id-type="doi">10.1016/j.farmac.2005.08.001</pub-id>
</citation>
</ref>
<ref id="B33">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kurhade</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Konstantinidou</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Sutanto</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Kurpiewska</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Kalinowska&#x2010;T&#x142;u&#x15b;cik</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>D&#xf6;mling</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Sequential multicomponent synthesis of 2-(Imidazo[1,5-&#x3b1;]pyridin-1-yl)-1,3,4-Oxadiazoles: Sequential multicomponent synthesis of 2-(Imidazo[1,5-&#x3b1;]pyridin-1-yl)-1,3,4-Oxadiazoles</article-title>. <source>Eur. J. Org. Chem.</source> <volume>10</volume>, <fpage>2029</fpage>&#x2013;<lpage>2034</lpage>. <pub-id pub-id-type="doi">10.1002/ejoc.201801880</pub-id>
</citation>
</ref>
<ref id="B34">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Leatham</surname>
<given-names>P. A.</given-names>
</name>
<name>
<surname>Bird</surname>
<given-names>H. A.</given-names>
</name>
<name>
<surname>Wright</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Seymour</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Gordon</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>1983</year>). <article-title>A double blind study of antrafenine, naproxen and placebo in osteoarthrosis</article-title>. <source>Eur. J. rheumatology Inflamm.</source> <volume>6</volume> (<issue>2</issue>), <fpage>209</fpage>&#x2013;<lpage>211</lpage>.</citation>
</ref>
<ref id="B35">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Su</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Jia</surname>
<given-names>X.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Unexpected isocyanide-based cascade cycloaddition reaction with methyleneindolinone</article-title>. <source>Chem. Commun.</source> <volume>49</volume> (<issue>91</issue>), <fpage>10694</fpage>&#x2013;<lpage>10696</lpage>. <pub-id pub-id-type="doi">10.1039/c3cc46237d</pub-id>
</citation>
</ref>
<ref id="B36">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lilienkampf</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Mao</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Wan</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Franzblau</surname>
<given-names>S. G.</given-names>
</name>
<name>
<surname>Kozikowski</surname>
<given-names>A. P.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Structure&#x2212; activity relationships for a series of quinoline-based compounds active against replicating and nonreplicating <italic>Mycobacterium tuberculosis</italic>
</article-title>. <source>J. Med. Chem.</source> <volume>52</volume> (<issue>7</issue>), <fpage>2109</fpage>&#x2013;<lpage>2118</lpage>. <pub-id pub-id-type="doi">10.1021/jm900003c</pub-id>
</citation>
</ref>
<ref id="B37">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lockshin</surname>
<given-names>R. A.</given-names>
</name>
<name>
<surname>Zakeri</surname>
<given-names>Z.</given-names>
</name>
</person-group> (<year>2004</year>). <article-title>Apoptosis, autophagy, and more</article-title>. <source>Int. J. Biochem. Cell Biol.</source> <volume>36</volume> (<issue>12</issue>), <fpage>2405</fpage>&#x2013;<lpage>2419</lpage>. <pub-id pub-id-type="doi">10.1016/j.biocel.2004.04.011</pub-id>
</citation>
</ref>
<ref id="B38">
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Lockshin</surname>
<given-names>R. A.</given-names>
</name>
<name>
<surname>Zakeri</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Tilly</surname>
<given-names>J. L.</given-names>
</name>
</person-group> (<year>1998</year>). <source>When cells die: A comprehensive evaluation of apoptosis and programmed cell death</source>. <publisher-loc>New Jersey, United States</publisher-loc>: <publisher-name>Wiley-Liss</publisher-name>.</citation>
</ref>
<ref id="B39">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Maguire</surname>
<given-names>M. P.</given-names>
</name>
<name>
<surname>Sheets</surname>
<given-names>K. R.</given-names>
</name>
<name>
<surname>McVety</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Spada</surname>
<given-names>A. P.</given-names>
</name>
<name>
<surname>Zilberstein</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>1994</year>). <article-title>A new series of PDGF receptor tyrosine kinase inhibitors: 3-substituted quinoline derivatives</article-title>. <source>J. Med. Chem.</source> <volume>37</volume> (<issue>14</issue>), <fpage>2129</fpage>&#x2013;<lpage>2137</lpage>. <pub-id pub-id-type="doi">10.1021/jm00040a003</pub-id>
</citation>
</ref>
<ref id="B40">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mahamoud</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Chevalier</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Davin-Regli</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Barbe</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Pages</surname>
<given-names>J. M.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>Quinoline derivatives as promising inhibitors of antibiotic efflux pump in multidrug resistant Enterobacter aerogenes isolates</article-title>. <source>Curr. drug targets</source> <volume>7</volume> (<issue>7</issue>), <fpage>843</fpage>&#x2013;<lpage>847</lpage>. <pub-id pub-id-type="doi">10.2174/138945006777709557</pub-id>
</citation>
</ref>
<ref id="B41">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mahboobi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Eichhorn</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Popp</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Sellmer</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Elz</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>M&#xf6;llmann</surname>
<given-names>U.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>3-Bromo-4-(1H-3-indolyl)-2, 5-dihydro-1H-2, 5-pyrroledione derivatives as new lead compounds for antibacterially active substances</article-title>. <source>Eur. J. Med. Chem.</source> <volume>41</volume> (<issue>2</issue>), <fpage>176</fpage>&#x2013;<lpage>191</lpage>. <pub-id pub-id-type="doi">10.1016/j.ejmech.2005.10.006</pub-id>
</citation>
</ref>
<ref id="B42">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mashayekh</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Shiri</surname>
<given-names>P.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>An overview of recent advances in the applications of click chemistry in the synthesis of bioconjugates with anticancer activities</article-title>. <source>ChemistrySelect</source> <volume>4</volume> (<issue>46</issue>), <fpage>13459</fpage>&#x2013;<lpage>13478</lpage>. <pub-id pub-id-type="doi">10.1002/slct.201902362</pub-id>
</citation>
</ref>
<ref id="B43">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Meki</surname>
<given-names>A. R. M.</given-names>
</name>
<name>
<surname>Esmail</surname>
<given-names>E. E. D. F.</given-names>
</name>
<name>
<surname>Hussein</surname>
<given-names>A. A.</given-names>
</name>
<name>
<surname>Hassanein</surname>
<given-names>H. M.</given-names>
</name>
</person-group> (<year>2004</year>). <article-title>Caspase-3 and heat shock protein-70 in rat liver treated with aflatoxin B1: Effect of melatonin</article-title>. <source>Toxicon</source> <volume>43</volume> (<issue>1</issue>), <fpage>93</fpage>&#x2013;<lpage>100</lpage>. <pub-id pub-id-type="doi">10.1016/j.toxicon.2003.10.026</pub-id>
</citation>
</ref>
<ref id="B44">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Michael</surname>
<given-names>J. P.</given-names>
</name>
</person-group> (<year>2001</year>). <article-title>Quinoline, quinazoline and acridone alkaloids (July 1999 to June 2000)</article-title>. <source>Nat. Product. Rep.</source> <volume>18</volume> (<issue>5</issue>), <fpage>543</fpage>&#x2013;<lpage>559</lpage>. <pub-id pub-id-type="doi">10.1039/b005387m</pub-id>
</citation>
</ref>
<ref id="B45">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Michael</surname>
<given-names>J. P.</given-names>
</name>
</person-group> (<year>2002</year>). <article-title>Quinoline, quinazoline and acridone alkaloids</article-title>. <source>Nat. Product. Rep.</source> <volume>19</volume> (<issue>6</issue>), <fpage>742</fpage>&#x2013;<lpage>760</lpage>. <pub-id pub-id-type="doi">10.1039/b104971m</pub-id>
</citation>
</ref>
<ref id="B46">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Michael</surname>
<given-names>J. P.</given-names>
</name>
</person-group> (<year>2003</year>). <article-title>Quinoline, quinazoline and acridone alkaloids</article-title>. <source>Nat. Product. Rep.</source> <volume>20</volume> (<issue>5</issue>), <fpage>476</fpage>&#x2013;<lpage>493</lpage>. <pub-id pub-id-type="doi">10.1039/b208140g</pub-id>
</citation>
</ref>
<ref id="B47">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Michael</surname>
<given-names>J. P.</given-names>
</name>
</person-group> (<year>2004</year>). <article-title>Quinoline, quinazoline and acridone alkaloids</article-title>. <source>Nat. Product. Rep.</source> <volume>21</volume> (<issue>5</issue>), <fpage>650</fpage>&#x2013;<lpage>668</lpage>. <pub-id pub-id-type="doi">10.1039/b310691h</pub-id>
</citation>
</ref>
<ref id="B48">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Michael</surname>
<given-names>J. P.</given-names>
</name>
</person-group> (<year>2005</year>). <article-title>Quinoline, quinazoline and acridone alkaloids</article-title>. <source>Nat. Product. Rep.</source> <volume>22</volume> (<issue>5</issue>), <fpage>627</fpage>&#x2013;<lpage>646</lpage>. <pub-id pub-id-type="doi">10.1039/b413750g</pub-id>
</citation>
</ref>
<ref id="B49">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Michael</surname>
<given-names>J. P.</given-names>
</name>
</person-group> (<year>2007</year>). <article-title>Quinoline, quinazoline and acridone alkaloids</article-title>. <source>Nat. Product. Rep.</source> <volume>24</volume> (<issue>1</issue>), <fpage>223</fpage>&#x2013;<lpage>246</lpage>. <pub-id pub-id-type="doi">10.1039/b509528j</pub-id>
</citation>
</ref>
<ref id="B50">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Michael</surname>
<given-names>J. P.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>Quinoline, quinazoline and acridone alkaloids</article-title>. <source>Nat. Product. Rep.</source> <volume>25</volume> (<issue>1</issue>), <fpage>166</fpage>&#x2013;<lpage>187</lpage>. <pub-id pub-id-type="doi">10.1039/b612168n</pub-id>
</citation>
</ref>
<ref id="B51">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mollin</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Blanck</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Harms</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Meggers</surname>
<given-names>E.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Cyclometalated phenylquinoline rhodium complexes as protein kinase inhibitors</article-title>. <source>Inorganica Chim. Acta</source> <volume>393</volume>, <fpage>261</fpage>&#x2013;<lpage>268</lpage>. <pub-id pub-id-type="doi">10.1016/j.ica.2012.04.035</pub-id>
</citation>
</ref>
<ref id="B52">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mortoni</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Martinelli</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Piarulli</surname>
<given-names>U.</given-names>
</name>
<name>
<surname>Regalia</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Gagliardi</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2004</year>). <article-title>Microwave-assisted solvent-free synthesis of a quinoline-3, 4-dicarboximide library on inorganic solid supports</article-title>. <source>Tetrahedron Lett.</source> <volume>45</volume> (<issue>35</issue>), <fpage>6623</fpage>&#x2013;<lpage>6627</lpage>. <pub-id pub-id-type="doi">10.1002/chin.200450111</pub-id>
</citation>
</ref>
<ref id="B53">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Muruganantham</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Sivakumar</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Anbalagan</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Gunasekaran</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Leonard</surname>
<given-names>J. T.</given-names>
</name>
</person-group> (<year>2004</year>). <article-title>Synthesis, anticonvulsant and antihypertensive activities of 8-substituted quinoline derivatives</article-title>. <source>Biol. Pharm. Bull.</source> <volume>27</volume> (<issue>10</issue>), <fpage>1683</fpage>&#x2013;<lpage>1687</lpage>. <pub-id pub-id-type="doi">10.1248/bpb.27.1683</pub-id>
</citation>
</ref>
<ref id="B54">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nasveld</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Kitchener</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2005</year>). <article-title>Treatment of acute vivax malaria with tafenoquine</article-title>. <source>Trans. R. Soc. Trop. Med. Hyg.</source> <volume>99</volume> (<issue>1</issue>), <fpage>2</fpage>&#x2013;<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1016/j.trstmh.2004.01.013</pub-id>
</citation>
</ref>
<ref id="B55">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Okun</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Malarchuk</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Dubrovskaya</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Khvat</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Tkachenko</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kysil</surname>
<given-names>V.</given-names>
</name>
<etal/>
</person-group> (<year>2006a</year>). <article-title>Screening for caspase-3 inhibitors: Effect of a reducing agent on identified hit chemotypes</article-title>. <source>J. Biomol. Screen.</source> <volume>11</volume> (<issue>6</issue>), <fpage>694</fpage>&#x2013;<lpage>703</lpage>. <pub-id pub-id-type="doi">10.1177/1087057106289231</pub-id>
</citation>
</ref>
<ref id="B56">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Okun</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Malarchuk</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Dubrovskaya</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Khvat</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Tkachenko</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kysil</surname>
<given-names>V.</given-names>
</name>
<etal/>
</person-group> (<year>2006b</year>). <article-title>Screening for caspase-3 inhibitors: A new class of potent small-molecule inhibitors of caspase-3</article-title>. <source>SLAS Discov.</source> <volume>11</volume> (<issue>3</issue>), <fpage>277</fpage>&#x2013;<lpage>285</lpage>. <pub-id pub-id-type="doi">10.1177/1087057105285048</pub-id>
</citation>
</ref>
<ref id="B57">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Patel</surname>
<given-names>D. B.</given-names>
</name>
<name>
<surname>Parmar</surname>
<given-names>J. A.</given-names>
</name>
<name>
<surname>Patel</surname>
<given-names>S. S.</given-names>
</name>
<name>
<surname>Naik</surname>
<given-names>U. J.</given-names>
</name>
<name>
<surname>Patel</surname>
<given-names>H. D.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Recent advances in ester synthesis by multi-component reactions (MCRs): A review</article-title>. <source>Curr. Org. Chem.</source> <volume>25</volume> (<issue>5</issue>), <fpage>539</fpage>&#x2013;<lpage>553</lpage>. <pub-id pub-id-type="doi">10.2174/1385272825666210111111805</pub-id>
</citation>
</ref>
<ref id="B58">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Porter</surname>
<given-names>A. G.</given-names>
</name>
<name>
<surname>J&#xe4;nicke</surname>
<given-names>R. U.</given-names>
</name>
</person-group> (<year>1999</year>). <article-title>Emerging roles of caspase-3 in apoptosis</article-title>. <source>Cell. death Differ.</source> <volume>6</volume> (<issue>2</issue>), <fpage>99</fpage>&#x2013;<lpage>104</lpage>. <pub-id pub-id-type="doi">10.1038/sj.cdd.4400476</pub-id>
</citation>
</ref>
<ref id="B59">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rezvanian</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Heravi</surname>
<given-names>M. M.</given-names>
</name>
<name>
<surname>Shaabani</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Tajbakhsh</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Five-component synthesis of dihydropyridines based on diketene</article-title>. <source>Tetrahedron</source> <volume>73</volume> (<issue>15</issue>), <fpage>2009</fpage>&#x2013;<lpage>2013</lpage>. <pub-id pub-id-type="doi">10.1016/j.tet.2017.02.027</pub-id>
</citation>
</ref>
<ref id="B60">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rezvanian</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Alinaghian</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Heravi</surname>
<given-names>M. M.</given-names>
</name>
</person-group> (<year>2018a</year>). <article-title>Metal&#x2010;free assemblage of four C&#x2212; N and two C&#x2212; C bonds via a cascade five component diastereoselective synthesis of pyrido [1, 2&#x2010;a] pyrimidines</article-title>. <source>ChemistrySelect</source> <volume>3</volume> (<issue>41</issue>), <fpage>11565</fpage>&#x2013;<lpage>11568</lpage>. <pub-id pub-id-type="doi">10.1002/slct.201802481</pub-id>
</citation>
</ref>
<ref id="B61">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rezvanian</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Alinaghian</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Heravi</surname>
<given-names>M. M.</given-names>
</name>
</person-group> (<year>2018b</year>). <article-title>Metal&#x2010;free assemblage of four C&#x2212; N and two C&#x2212; C bonds via a cascade five component diastereoselective synthesis of pyrido [1, 2&#x2010;a] pyrimidines</article-title>. <source>ChemistrySelect</source> <volume>3</volume> (<issue>41</issue>), <fpage>11565</fpage>&#x2013;<lpage>11568</lpage>. <pub-id pub-id-type="doi">10.1002/slct.201802481</pub-id>
</citation>
</ref>
<ref id="B62">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rezvanian</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Babashah</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Anafcheh</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>A novel pseudo six-component synthesis of functionalized pyrazoles in ethanol by cascade reaction</article-title>. <source>Mol. Divers.</source> <volume>23</volume> (<issue>4</issue>), <fpage>875</fpage>&#x2013;<lpage>883</lpage>. <pub-id pub-id-type="doi">10.1007/s11030-018-9908-2</pub-id>
</citation>
</ref>
<ref id="B63">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rezvanian</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Moradi</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Zadsirjan</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Mohammadnejad</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Heravi</surname>
<given-names>M. M.</given-names>
</name>
</person-group> (<year>2020a</year>). <article-title>Cascade process for direct synthesis of indeno [1, 2-b] furans and indeno [1, 2-b] pyrroles from diketene and ninhydrin</article-title>. <source>Mol. Divers.</source> <volume>24</volume> (<issue>4</issue>), <fpage>1313</fpage>&#x2013;<lpage>1325</lpage>. <pub-id pub-id-type="doi">10.1007/s11030-019-09996-7</pub-id>
</citation>
</ref>
<ref id="B64">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rezvanian</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Moradi</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Zadsirjan</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Mohammadnejad</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Heravi</surname>
<given-names>M. M.</given-names>
</name>
</person-group> (<year>2020b</year>). <article-title>Cascade process for direct synthesis of indeno [1, 2-b] furans and indeno [1, 2-b] pyrroles from diketene and ninhydrin</article-title>. <source>Mol. Divers.</source> <volume>24</volume> (<issue>4</issue>), <fpage>1313</fpage>&#x2013;<lpage>1325</lpage>. <pub-id pub-id-type="doi">10.1007/s11030-019-09996-7</pub-id>
</citation>
</ref>
<ref id="B65">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rezvanian</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Moradi</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Zadsirjan</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Mohammadnejad</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Heravi</surname>
<given-names>M. M.</given-names>
</name>
</person-group> (<year>2020c</year>). <article-title>Cascade process for direct synthesis of indeno [1, 2-b] furans and indeno [1, 2-b] pyrroles from diketene and ninhydrin</article-title>. <source>Mol. Divers.</source> <volume>24</volume> (<issue>4</issue>), <fpage>1313</fpage>&#x2013;<lpage>1325</lpage>. <pub-id pub-id-type="doi">10.1007/s11030-019-09996-7</pub-id>
</citation>
</ref>
<ref id="B66">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rezvanian</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Mahmoodi</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Zadsirjan</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Salimi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Heravi</surname>
<given-names>M. M.</given-names>
</name>
</person-group> (<year>2020d</year>). <article-title>Efficient and uncatalyzed synthesis of highly functionalized new symmetrical indeno [1, 2&#x2010;b] pyrroles via a one&#x2010;pot four&#x2010;component reaction</article-title>. <source>ChemistrySelect</source> <volume>5</volume> (<issue>12</issue>), <fpage>3503</fpage>&#x2013;<lpage>3507</lpage>. <pub-id pub-id-type="doi">10.1002/slct.201904860</pub-id>
</citation>
</ref>
<ref id="B67">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rezvanian</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Noorakhtar</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Ziarani</surname>
<given-names>G. M.</given-names>
</name>
<name>
<surname>Mahajer</surname>
<given-names>F.</given-names>
</name>
</person-group> (<year>2020e</year>). <article-title>Quinoline conjugated imidazopyridine and pyridopyrimidine synthesis in water as highly selective fluoride sensors via a catalyst-free four-component reaction</article-title>. <source>Monatsh. f&#xfc;r Chemie-Chemical Mon.</source> <volume>151</volume> (<issue>10</issue>), <fpage>1581</fpage>&#x2013;<lpage>1589</lpage>. <pub-id pub-id-type="doi">10.1007/s00706-020-02681-8</pub-id>
</citation>
</ref>
<ref id="B68">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rezvanian</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Kuhzadeh</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Roosta</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2021a</year>). <article-title>Synthesis of novel 1, 3&#x2010;cyclohexadiene derivatives bearing 2&#x2010;oxo&#x2010;quinoline moiety via a 4&#x2010;CR strategy</article-title>. <source>ChemistrySelect</source> <volume>6</volume> (<issue>45</issue>), <fpage>12965</fpage>&#x2013;<lpage>12969</lpage>. <pub-id pub-id-type="doi">10.1002/slct.202103240</pub-id>
</citation>
</ref>
<ref id="B69">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rezvanian</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Amoozadkhalili</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Roosta</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2021b</year>). <article-title>Sequential four-component protocol for the synthesis of pyrido [1, 2-a] pyrimidin-6-one derivatives in water</article-title>. <source>Chem. Pap.</source> <volume>75</volume> (<issue>6</issue>), <fpage>2417</fpage>&#x2013;<lpage>2424</lpage>. <pub-id pub-id-type="doi">10.1007/s11696-020-01450-5</pub-id>
</citation>
</ref>
<ref id="B70">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rezvanian</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Iodine catalyzed mild 4CR protocol for synthesis of tetrahydroimidazo [1, 2-a] pyridines: Cascade construction of multiple C&#x2013;C and C&#x2013;hetero bonds</article-title>. <source>Tetrahedron</source> <volume>71</volume> (<issue>29</issue>), <fpage>4752</fpage>&#x2013;<lpage>4756</lpage>. <pub-id pub-id-type="doi">10.1016/j.tet.2015.05.062</pub-id>
</citation>
</ref>
<ref id="B71">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rezvanian</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>An expedient synthesis strategy to the 1, 4-dihydropyridines and pyrido [1, 2-a] quinoxalines: Iodine catalyzed one-pot four-component domino reactions</article-title>. <source>Tetrahedron</source> <volume>72</volume> (<issue>41</issue>), <fpage>6428</fpage>&#x2013;<lpage>6435</lpage>. <pub-id pub-id-type="doi">10.1016/j.tet.2016.08.049</pub-id>
</citation>
</ref>
<ref id="B72">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Russ</surname>
<given-names>T. H.</given-names>
</name>
<name>
<surname>Pramanik</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Khansari</surname>
<given-names>M. E.</given-names>
</name>
<name>
<surname>Wong</surname>
<given-names>B. M.</given-names>
</name>
<name>
<surname>Hossain</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>A quinoline based bis-urea receptor for anions: A selective receptor for hydrogen sulfate</article-title>. <source>Nat. Product. Commun.</source> <volume>7</volume> (<issue>3</issue>), <fpage>1934578X1200700</fpage>&#x2013;<lpage>304</lpage>. <pub-id pub-id-type="doi">10.1177/1934578x1200700307</pub-id>
</citation>
</ref>
<ref id="B73">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Scott</surname>
<given-names>C. W.</given-names>
</name>
<name>
<surname>Sobotka-Briner</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Wilkins</surname>
<given-names>D. E.</given-names>
</name>
<name>
<surname>Jacobs</surname>
<given-names>R. T.</given-names>
</name>
<name>
<surname>Folmer</surname>
<given-names>J. J.</given-names>
</name>
<name>
<surname>Frazee</surname>
<given-names>W. J.</given-names>
</name>
<etal/>
</person-group> (<year>2003</year>). <article-title>Novel small molecule inhibitors of caspase-3 block cellular and biochemical features of apoptosis</article-title>. <source>J. Pharmacol. Exp. Ther.</source> <volume>304</volume> (<issue>1</issue>), <fpage>433</fpage>&#x2013;<lpage>440</lpage>. <pub-id pub-id-type="doi">10.1124/jpet.102.039651</pub-id>
</citation>
</ref>
<ref id="B74">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sedighian</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Mamaghani</surname>
<given-names>M. B.</given-names>
</name>
<name>
<surname>Notash</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Bazgir</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Iodide-catalyzed selenium-assisted sequential multicomponent synthesis of a luminescence benzo-oxazino-isoindole framework</article-title>. <source>J. Org. Chem.</source> <volume>86</volume> (<issue>3</issue>), <fpage>2244</fpage>&#x2013;<lpage>2253</lpage>. <pub-id pub-id-type="doi">10.1021/acs.joc.0c02391</pub-id>
</citation>
</ref>
<ref id="B75">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Segawa</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Tsuzuike</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Itokazu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Omata</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Inoue</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Nagasawa</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2001</year>). <article-title>Effects of a novel hepatoprotective drug, ZNC-2381, on Fas-induced hepatocellular caspase-3 activity and apoptosis in mice</article-title>. <source>Pharmacology</source> <volume>62</volume> (<issue>2</issue>), <fpage>80</fpage>&#x2013;<lpage>86</lpage>. <pub-id pub-id-type="doi">10.1159/000056075</pub-id>
</citation>
</ref>
<ref id="B76">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Segura-Cabrera</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Rojo-Dom&#xed;nguez</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Rodr&#xed;guez-P&#xe9;rez</surname>
<given-names>M. A.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Integrative computational protocol for the discovery of inhibitors of the <italic>Helicobacter pylori</italic> nickel response regulator (NikR)</article-title>. <source>J. Mol. Model.</source> <volume>17</volume> (<issue>12</issue>), <fpage>3075</fpage>&#x2013;<lpage>3084</lpage>. <pub-id pub-id-type="doi">10.1007/s00894-011-0962-2</pub-id>
</citation>
</ref>
<ref id="B77">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sharma</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ravichandran</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Jain</surname>
<given-names>P. K.</given-names>
</name>
<name>
<surname>Mourya</surname>
<given-names>V. K.</given-names>
</name>
<name>
<surname>Agrawal</surname>
<given-names>R. K.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>Prediction of caspase-3 inhibitory activity of 1, 3-dioxo-4-methyl-2, 3-dihydro-1h-pyrrolo [3, 4-c] quinolines: QSAR study</article-title>. <source>J. Enzyme Inhibition Med. Chem.</source> <volume>23</volume> (<issue>3</issue>), <fpage>424</fpage>&#x2013;<lpage>431</lpage>. <pub-id pub-id-type="doi">10.1080/14756360701652476</pub-id>
</citation>
</ref>
<ref id="B78">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sharma</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Das</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Gogoi</surname>
<given-names>P.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Synthesis of pyrrolo [3, 4-c] quinoline-1, 3-diones: A sequential oxidative annulation followed by dehydrogenation and N-demethylation strategy</article-title>. <source>New J. Chem.</source> <volume>42</volume> (<issue>23</issue>), <fpage>18894</fpage>&#x2013;<lpage>18905</lpage>. <pub-id pub-id-type="doi">10.1039/c8nj04443k</pub-id>
</citation>
</ref>
<ref id="B79">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shiri</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Aboonajmi</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>A systematic review on silica-carbon-and magnetic materials-supported copper species as efficient heterogeneous nanocatalysts in &#x201c;click&#x201d; reactions</article-title>. <source>Beilstein J. Org. Chem.</source> <volume>16</volume> (<issue>1</issue>), <fpage>551</fpage>&#x2013;<lpage>586</lpage>. <pub-id pub-id-type="doi">10.3762/bjoc.16.52</pub-id>
</citation>
</ref>
<ref id="B80">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shiri</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Niknam</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Aboonajmi</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Khalafi-Nezhad</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Amani</surname>
<given-names>A. M.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>A quick access to structurally diverse triazoloquinazoline heterocycles via the MIL-101 (Cr)-Catalyzed one-pot multi-component reaction of a series of benzaldehydes, dimedone, and 1H-1, 2, 4-triazol-3-amine under green conditions</article-title>. <source>Front. Chem.</source> <volume>10</volume>, <fpage>898658</fpage>. <pub-id pub-id-type="doi">10.3389/fchem.2022.898658</pub-id>
</citation>
</ref>
<ref id="B81">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shukla</surname>
<given-names>S. P.</given-names>
</name>
<name>
<surname>Tiwari</surname>
<given-names>R. K.</given-names>
</name>
<name>
<surname>Verma</surname>
<given-names>A. K.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Palladium-catalyzed sonogashira-coupling conjoined C&#x2013;H activation: A regioselective tandem strategy to access indolo-and pyrrolo [1, 2-a] quinolines</article-title>. <source>J. Org. Chem.</source> <volume>77</volume> (<issue>22</issue>), <fpage>10382</fpage>&#x2013;<lpage>10392</lpage>. <pub-id pub-id-type="doi">10.1021/jo302112a</pub-id>
</citation>
</ref>
<ref id="B82">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Slater</surname>
<given-names>M. J.</given-names>
</name>
<name>
<surname>Cockerill</surname>
<given-names>G. S.</given-names>
</name>
<name>
<surname>Robinson</surname>
<given-names>J. E.</given-names>
</name>
</person-group> (<year>1995</year>). <article-title>Preparation of antiviral heterocyclylindole derivatives PCT WO 95/07,910</article-title>. <source>Chem. Abstr.</source> <volume>123</volume>, <fpage>256682</fpage>.</citation>
</ref>
<ref id="B83">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Strekowski</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Mokrosz</surname>
<given-names>J. L.</given-names>
</name>
<name>
<surname>Honkan</surname>
<given-names>V. A.</given-names>
</name>
<name>
<surname>Czarny</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Cegla</surname>
<given-names>M. T.</given-names>
</name>
<name>
<surname>Wydra</surname>
<given-names>R. L.</given-names>
</name>
<etal/>
</person-group> (<year>1991</year>). <article-title>Synthesis and quantitative structure-activity relationship analysis of 2-(aryl or heteroaryl) quinolin-4-amines, a new class of anti-HIV-1 agents</article-title>. <source>J. Med. Chem.</source> <volume>34</volume> (<issue>5</issue>), <fpage>1739</fpage>&#x2013;<lpage>1746</lpage>. <pub-id pub-id-type="doi">10.1021/jm00109a031</pub-id>
</citation>
</ref>
<ref id="B84">
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Summa</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Pace</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Di</surname>
<given-names>F. M. E.</given-names>
</name>
<name>
<surname>Martin</surname>
<given-names>H. J. I.</given-names>
</name>
<name>
<surname>Nizi</surname>
<given-names>E.</given-names>
</name>
</person-group> (<year>2009</year>). <source>UK pat.; GB2450771A</source>. .</citation>
</ref>
<ref id="B85">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sun</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>Z. M.</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>H. L.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Synthesis, molecular modeling and biological evaluation of 2-aminomethyl-5-(quinolin-2-yl)-1, 3, 4-oxadiazole-2 (3H)-thione quinolone derivatives as novel anticancer agent</article-title>. <source>Eur. J. Med. Chem.</source> <volume>60</volume>, <fpage>23</fpage>&#x2013;<lpage>28</lpage>. <pub-id pub-id-type="doi">10.1016/j.ejmech.2012.11.039</pub-id>
</citation>
</ref>
<ref id="B86">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Talaei</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Heravi</surname>
<given-names>M. M.</given-names>
</name>
<name>
<surname>Oskooie</surname>
<given-names>H. A.</given-names>
</name>
<name>
<surname>Rezvanian</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>An approach to the diastereoselective synthesis of cyclohexane-1, 3-dicarboxamide derivatives via a pseudo five-component reaction based on diketene</article-title>. <source>Synlett</source> <volume>29</volume> (<issue>02</issue>), <fpage>225</fpage>&#x2013;<lpage>229</lpage>. <pub-id pub-id-type="doi">10.1055/s-0036-1590980</pub-id>
</citation>
</ref>
<ref id="B87">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Thomas</surname>
<given-names>J. W.</given-names>
</name>
<name>
<surname>Tallman</surname>
<given-names>J. F.</given-names>
</name>
</person-group> (<year>1981</year>). <article-title>Characterization of photoaffinity labeling of benzodiazepine binding sites</article-title>. <source>J. Biol. Chem.</source> <volume>256</volume> (<issue>19</issue>), <fpage>9838</fpage>&#x2013;<lpage>9842</lpage>. <pub-id pub-id-type="doi">10.1016/s0021-9258(19)68705-3</pub-id>
</citation>
</ref>
<ref id="B88">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tseng</surname>
<given-names>C. H.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Y. L.</given-names>
</name>
<name>
<surname>Chung</surname>
<given-names>K. Y.</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>C. M.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>C. H.</given-names>
</name>
<name>
<surname>Tzeng</surname>
<given-names>C. C.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Synthesis and antiproliferative evaluation of 6-arylindeno [1, 2-c] quinoline derivatives</article-title>. <source>Bioorg. Med. Chem.</source> <volume>17</volume> (<issue>21</issue>), <fpage>7465</fpage>&#x2013;<lpage>7476</lpage>. <pub-id pub-id-type="doi">10.1016/j.bmc.2009.09.021</pub-id>
</citation>
</ref>
<ref id="B89">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tseng</surname>
<given-names>C. H.</given-names>
</name>
<name>
<surname>Tzeng</surname>
<given-names>C. C.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>C. L.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>P. J.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>H. L.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>H. Y.</given-names>
</name>
<etal/>
</person-group> (<year>2010</year>). <article-title>Synthesis and antiproliferative evaluation of certain indeno [1, 2-c] quinoline derivatives. Part 2</article-title>. <source>J. Med. Chem.</source> <volume>53</volume> (<issue>16</issue>), <fpage>6164</fpage>&#x2013;<lpage>6179</lpage>. <pub-id pub-id-type="doi">10.1021/jm1005447</pub-id>
</citation>
</ref>
<ref id="B90">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Valeriote</surname>
<given-names>F. A.</given-names>
</name>
<name>
<surname>Tenney</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Pietraszkiewicz</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Edelstein</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Johnson</surname>
<given-names>T. A.</given-names>
</name>
<name>
<surname>Amagata</surname>
<given-names>T.</given-names>
</name>
<etal/>
</person-group> (<year>2012</year>). <article-title>Discovery and development of anticancer agents from marine sponges: Perspectives based on a chemistry-experimental therapeutics collaborative program</article-title>. <source>J. Exp. Ther. Oncol.</source> <volume>10</volume> (<issue>2</issue>), <fpage>119</fpage>&#x2013;<lpage>134</lpage>.</citation>
</ref>
<ref id="B91">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wald</surname>
<given-names>K. M.</given-names>
</name>
<name>
<surname>Nada</surname>
<given-names>A. A.</given-names>
</name>
<name>
<surname>Szil&#xe1;gyi</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Wamhoff</surname>
<given-names>H.</given-names>
</name>
</person-group> (<year>1980</year>). <article-title>Photochemie von Heterocyclen, 9. Zur anellierenden Photosubstitution von Dibrom&#x2010;N&#x2010;methylmaleinimid (DBMI)</article-title>. <source>Chem. Berichte</source> <volume>113</volume> (<issue>9</issue>), <fpage>2884</fpage>&#x2013;<lpage>2890</lpage>. <pub-id pub-id-type="doi">10.1002/cber.19801130907</pub-id>
</citation>
</ref>
<ref id="B92">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wilson</surname>
<given-names>W. D.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Patterson</surname>
<given-names>S. E.</given-names>
</name>
<name>
<surname>Wydra</surname>
<given-names>R. L.</given-names>
</name>
<name>
<surname>Janda</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Strekowski</surname>
<given-names>L.</given-names>
</name>
<etal/>
</person-group> (<year>1992</year>). <article-title>Design of RNA interactive anti&#x2010;HIV&#x2010;1 agents: Unfused aromatic intercalators</article-title>. <source>ChemInform</source> <volume>23</volume> (<issue>44</issue>), <fpage>1739</fpage>&#x2013;<lpage>1746</lpage>.</citation>
</ref>
<ref id="B93">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xia</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Idhayadhulla</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>Y. R.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>S. H.</given-names>
</name>
<name>
<surname>Wee</surname>
<given-names>Y. J.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Microwave-assisted synthesis of diverse pyrrolo [3, 4-c] quinoline-1, 3-diones and their antibacterial activities</article-title>. <source>ACS Comb. Sci.</source> <volume>16</volume> (<issue>7</issue>), <fpage>333</fpage>&#x2013;<lpage>341</lpage>. <pub-id pub-id-type="doi">10.1021/co500002s</pub-id>
</citation>
</ref>
<ref id="B94">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yavari</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Safaei</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Synthesis of functionalized &#x3b3;-spiroiminolactones from isocyanides, acetylenic esters, and cyclopenta [a] acenaphthylen-8-ones</article-title>. <source>Synth. Commun.</source> <volume>50</volume> (<issue>14</issue>), <fpage>2156</fpage>&#x2013;<lpage>2162</lpage>. <pub-id pub-id-type="doi">10.1080/00397911.2020.1765389</pub-id>
</citation>
</ref>
<ref id="B95">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Younus</surname>
<given-names>H. A.</given-names>
</name>
<name>
<surname>Al-Rashida</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Hameed</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Uroos</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Salar</surname>
<given-names>U.</given-names>
</name>
<name>
<surname>Rana</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Multicomponent reactions (MCR) in medicinal chemistry: A patent review (2010-2020)</article-title>. <source>Expert Opin. Ther. Pat.</source> <volume>31</volume> (<issue>3</issue>), <fpage>267</fpage>&#x2013;<lpage>289</lpage>. <pub-id pub-id-type="doi">10.1080/13543776.2021.1858797</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>